The use of real-time PCR technique in the detection of novel protein 4.2 gene mutations that coexist with thalassaemia alpha in a single patient

Eur J Haematol. 2009 Oct;83(4):373-7. doi: 10.1111/j.1600-0609.2009.01289.x. Epub 2009 Jun 8.

Abstract

Alpha-thalassaemia is a very rare disease in Northern Europe in contrast to hereditary spherocytosis that is associated with red blood cell membrane defects. We report here alpha-thalassaemia case who was also found to bear the erythrocyte membrane protein 4.2 gene mutations. mRNA relative quantification of red cell membrane protein genes in a Polish patient with alpha-thalassaemia trait indicated EPB42 as the gene that could also be involved in anaemia pathogenesis. Sequencing revealed the presence of two novel mutations in the protein 4.2 gene: a G1701A genetic change that predicts an alanine to threonine at position 567 of the protein (A567T) and a T-->A substitution that is located at position +6 of the donor splice site of intron 2 (IVS2nt+6T>A). This is the sixth variant of the erythrocyte membrane protein 4.2 gene mutations identified outside the Japanese population.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Cytoskeletal Proteins / genetics*
  • Erythrocyte Membrane / chemistry
  • Female
  • Humans
  • Membrane Proteins / genetics*
  • Mutation*
  • Polymerase Chain Reaction / methods
  • RNA, Messenger / analysis
  • alpha-Thalassemia / genetics*

Substances

  • Cytoskeletal Proteins
  • Membrane Proteins
  • RNA, Messenger
  • erythrocyte membrane band 4.2 protein